HOME >> BIOLOGY >> NEWS
Cystic Fibrosis Conference Will Showcase Latest From Clinical Care To Basic Science

The Twelfth Annual North American Cystic Fibrosis Conference, October 15-18, 1998 in Montreal, Quebec, Canada, promises to break attendance records as participants from around the world meet to share discoveries about cystic fibrosis (CF). Co-sponsored this year by the Cystic Fibrosis Foundation and the Canadian CF Foundation, more than 2,800 participants will be on hand as the complete spectrum of CF research and care will be presented at the Palais des Congres de Montreal.

Progress will be reported from a host of different fields. Many researchers seek to understand CF through basic cellular and molecular biology. Several sessions will cover what is known about the CF gene's protein, CFTR, for example. Strategies are already in clinical trials to correct the defective protein with many more planned.

Advances in CF gene therapy will also be presented. The focus now centers on examining the barriers to successful gene therapy, such as the body's own immune system. Other topics include the complex microbiology of CF, which involves pathogens that change shape and airway fluid with unique properties. New concepts in clinical care, as well as the social and psychological aspects of the disease, will also be discussed. Four days worth of symposia, workshops and hundreds of posters will be presented during the conference.

Research highlights will be presented in the form of three plenary sessions:
Oct. 16, 8:30 a.m. - 10:30 a.m., The Best of 1998, will feature:

  • How do we increase gene transfer efficiency?
  • Potential of antimicrobial peptides for therapeutic use in CF
  • Designing strategies to correct the Delta-F508 CFTR protein folding defect
  • Is there a role for newborn screening and early diagnosis in CF care?
  • Long-term efficacy and safety of inhaled tobramycin (TOBI) in patients with CF

Oct. 17, 9:00 a.m. - 10:00 a.m., CFTR Structure & Function: Pathophysiologic Insights & Novel Targets for Pharmacotherapies.
'"/>

Contact: Carolyn Habbersett
chabber@cff.org
301-951-4422
Cystic Fibrosis Foundation
5-Oct-1998


Page: 1 2

Related biology news :

1. Cystic fibrosis gene linked to fatty acid defects
2. Cystic fibrosis gene therapy trial results encouraging
3. Cystic fibrosis gene mutations missing from some cases
4. Cystic fibrosis patients show too little salt in lungs, will need long-lasting treatments
5. Cystic fibrosis splicing experiments offer hope for improved treatments
6. Cystic fibrosis gene undetected in screening of infertile men
7. UI Researchers Find Potential Gene Therapy For Cystic Fibrosis
8. Lack Of Intestinal Bacterium Linked To Kidney Stones In Cystic Fibrosis Patients, University Of Florida Researchers Report
9. Debilitating Pancreatic Disorder Linked To Cystic Fibrosis Gene
10. Shellfish Toxin Study Provides Possible Clue To Cystic Fibrosis Therapy
11. Successful Specialist Care For Cystic Fibrosis Patients From Childhood To Adulthood

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:9/12/2018)... ... September 12, 2018 , ... ... education, is pleased to support the professional development of academic librarians by sponsoring ... , The entrants were asked to submit successful strategies to increase collaboration among ...
(Date:9/7/2018)... ... September 06, 2018 , ... ... and sister to show Sensors Expo & Conference , announces their ... University, CA to conduct an IoT Enabled Industrial IoT Certification Program. Taking place ...
(Date:8/31/2018)... ... 2018 , ... R3 Stem Cell, the nation's leader in ... The freezers are very convenient for practices to maintain regenerative biologics on hand ... and umbilical cord tissue. They are stored at -80 degrees Celsius, which keeps ...
Breaking Biology News(10 mins):
(Date:8/23/2018)... ... August 23, 2018 , ... Visikol began its journey in ... Through support from advisors, mentors, the Rutgers Technology Transfer team and Foundation Venture Capital ... an idea to a successful biotech company has been a circuitous path but was ...
(Date:8/17/2018)... ... August 16, 2018 , ... ... pleased to announce the expansion of their team. Dr. Dawn Dufield, Ph.D., joins ... an innovative large molecule LC-MS/MS group that will specialize in developing quantitative LC-MS/MS ...
(Date:8/14/2018)... YORBA LINDA, Calif. (PRWEB) , ... August 14, ... ... opioid, an important drug for treating opioid use disorder. BUP is often prescribed ... parenteral use and diversion. , In this webinar, participants will learn from ...
(Date:8/9/2018)... ... August 08, 2018 , ... ActX introduces GenoACT(sm), a ... updated by a talented scientific team that includes geneticists, PharmD’s, genetic counselors, and ... Information on the medical impact of a patient’s genetic variants , 2. Educational ...
Breaking Biology Technology:
Cached News: